Sep 16, 2020 | Drug Costs, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss what goes into a drug price. They pull the curtain to reveal the group of middlemen between drugmakers and the patient that drives up the drug prices patients pay. They highlight the bizarre system of drug rebates,...
Aug 29, 2020 | Featured, Podcast
On this episode of the podcast, Terry and Bob explore how to speed up the development of new cures and treatments for rare and chronic diseases. Currently, a new cure takes about ten years and $2 billion. Patients don’t have that much time. There are more...
Aug 22, 2020 | Featured, ICER, Podcast, QALY
On this week’s episode of the podcast, Terry and Bob discuss how a Boston nonprofit called the Institute for Clinical and Economic Review (ICER) threatens healthcare for millions of Americans with chronic diseases. Terry and Bob discussed the pernicious...
Aug 15, 2020 | COVID-19, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss adapting to a Covid-19 world. Unfortunately, Covid-19 will be with us for some time, and Americans will need to learn to calibrate risk and reward in this new environment — as disheartening as that reality...
Aug 9, 2020 | Featured, Federal Issues, Podcast
On this episode of the podcast Terry, Kate, and Bob discuss the effort by patients, patients rights groups, and entrepreneurs to access personal health records. Under HIPAA, patients ostensibly own all their personal health information. Yet, for a variety of reasons,...
Aug 2, 2020 | Drug Costs, Featured, Podcast
On this week’s episode of the Patient’s Rising podcast, Terry and Bob discuss President Trump’s executive orders on prescription drug prices. Recently, Trump signed a series of Executive Orders that direct U.S. Health and Human Services to take steps...
